LCTX
AMEX · Biotechnology
Lineage Cell Therapeutics In
$0.99
-0.04 (-3.45%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,964.4% upside
Low Target
$29.91
Average Target
$40.42
High Target
$53.83
Current Price
$0.99
Current
$0.99
$0.99
Target
$40.42
$40.42
$29.91
$40.42 avg
$53.83
Scenario Analysis
Bear Case
$29.91
2,907.5%
Low target
Base Case
$40.42
+3,964.4%
Avg target
Bull Case
$53.83
+5,312.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.09
-52.4% from high
52-Week Low
$0.88
+12.7% from low
Target vs 52W High
$40.42
+1,834.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |